Clinical trial

Safety and IOP-Lowering Effects of WB007

NCT04149899

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-11-14

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2019-11-14Date precision: day

Registry last updated2025-03-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Glaucoma, Primary Open Angleunresolved

Ocular Hypertensionunresolved

Interventions

WB007 0.05%DRUG

WB007 0.15%DRUG

Timolol 0.5%DRUG

Sponsors & collaborators

Bausch & Lomb Incorporatedlead sponsor

Mapped research locations

Newport BeachCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04149899 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.